Cargando…

Current status and outcomes of patients developing PSA recurrence after prostatectomy who were treated with salvage radiotherapy: a JROSG surveillance study

The conditions and outcomes of Japanese patients with prostate cancer who developed PSA failure after radical prostatectomy (RP), and who were treated via salvage radiotherapy (S-RT), were surveyed. Clinical data on S-RT were gathered in questionnaires completed by facilities participating in the Ja...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mizowaki, Takashi, Aoki, Manabu, Nakamura, Katsumasa, Yorozu, Atsunori, Kokubo, Masaki, Karasawa, Katsuyuki, Kozuka, Takuyo, Nakajima, Nobuaki, Sasai, Keisuke, Akimoto, Tetsuo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497400/ https://www.ncbi.nlm.nih.gov/pubmed/25910489 http://dx.doi.org/10.1093/jrr/rrv027

Ejemplares similares

Adjuvant radiotherapy after prostatectomy for prostate cancer in Japan: a multi-institutional survey study of the JROSG
por: Aoki, Manabu, et al.
Publicado: (2014)

Organ-preserving approach via radiotherapy for small cell carcinoma of the bladder: an analysis based on the Japanese Radiation Oncology Study Group (JROSG) survey
por: Akamatsu, Hiroko, et al.
Publicado: (2019)

National survey of myeloablative total body irradiation prior to hematopoietic stem cell transplantation in Japan: survey of the Japanese Radiation Oncology Study Group (JROSG)
por: Ishibashi, Naoya, et al.
Publicado: (2018)

Comparison Between Dose-Escalated Intensity Modulated Radiation Therapy and 3-Dimensional Conformal Radiation Therapy for Salvage Radiation Therapy After Prostatectomy
por: Shimoyachi, Nana, et al.
Publicado: (2021)

Patterns of radiotherapy practice for biliary tract cancer in Japan: results of the Japanese radiation oncology study group (JROSG) survey
por: Isohashi, Fumiaki, et al.
Publicado: (2013)

Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience
por: Quero, Laurent, et al.
Publicado: (2008)

The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy
por: Ishikawa, Hitoshi, et al.
Publicado: (2020)

Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience
por: Murgic, Jure, et al.
Publicado: (2021)

Whole-gland salvage treatment for recurrent prostate cancer after initial definitive radiotherapy: A case series of (125)I brachytherapy and robot-assisted radical prostatectomy
por: Sutani, Shinya, et al.
Publicado: (2019)

What is the possible role of PSA doubling time (PSADT) and PSA velocity (PSAV) in the decision-making process to initiate salvage radiotherapy following radical prostatectomy in patients with prostate cancer?
por: Milecki, Piotr, et al.
Publicado: (2011)

Dual-timing PSA as a biomarker for patients with salvage intensity modulated radiation therapy for biochemical failure after radical prostatectomy
por: Wang, Yu-Jen, et al.
Publicado: (2016)

Prognostic significance of a novel indicator (PSA(postd3)/PSA(pre)) for PSA recurrence in patients after radical prostatectomy
por: Zhou, Zhien, et al.
Publicado: (2019)

Salvage robotic radical prostatectomy
por: Kaffenberger, Samuel D., et al.
Publicado: (2014)

Impact of (68)Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy
por: Bluemel, Christina, et al.
Publicado: (2016)

The natural history of a delayed detectable PSA after radical prostatectomy
por: Szymaniak, Julie A., et al.
Publicado: (2023)

Introduction of salvage prostatectomy in Denmark: the initial experience
por: Mortensen, Mike Allan, et al.
Publicado: (2022)

Final results from a multicenter prospective study ( JROSG 05–5) on postoperative radiotherapy for patients with ductal carcinoma in situ with an involved surgical margin or close margin widths of 1 mm or less
por: Shikama, Naoto, et al.
Publicado: (2015)

Salvage radiotherapy for biochemical relapse after complete PSA response following radical prostatectomy: outcome and prognostic factors for patients who have never received hormonal therapy
por: Jacinto, Alexandre A, et al.
Publicado: (2007)

PSA mass as a marker of prostate cancer progression after radical prostatectomy
por: Bryniarski, Piotr, et al.
Publicado: (2011)

Heterophilic Antibodies Resulting in False Positive Elevation of PSA After Radical Prostatectomy
por: Asha, Wafa, et al.
Publicado: (2023)

Who should receive single-fraction palliative radiotherapy for gastric cancer bleeding?: An exploratory analysis of a multicenter prospective observational study (JROSG 17-3)
por: Sekii, Shuhei, et al.
Publicado: (2023)

Dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring of liver tumors using a gimbal-mounted linac: A multi-institutional phase II study
por: Iizuka, Yusuke, et al.
Publicado: (2023)

Three Months’ PSA and Toxicity from a Prospective Trial Investigating STereotactic sAlvage Radiotherapy for Macroscopic Prostate Bed Recurrence after Prostatectomy—STARR (NCT05455736)
por: Francolini, Giulio, et al.
Publicado: (2023)

Efficacy of salvage stereotactic radiotherapy for recurrent glioma: impact of tumor morphology and method of target delineation on local control
por: Ogura, Kengo, et al.
Publicado: (2013)

Technical caveats in salvage robot assisted radical prostatectomy
por: Tamhankar, Ashwin, et al.
Publicado: (2020)

Salvage Radiotherapy after Radical Prostatectomy: Prediction of Biochemical Outcomes
por: Kwon, Ohseong, et al.
Publicado: (2014)

Robotic Salvage Lymph Node Dissection After Radical Prostatectomy
por: Torricelli, Fabio C. M., et al.
Publicado: (2015)

Salvage Radiotherapy for Macroscopic Local Recurrence Following Radical Prostatectomy
por: Zaine, Hind, et al.
Publicado: (2021)

Oncologic Outcomes of Lymph Node Dissection at Salvage Radical Prostatectomy
por: Preisser, Felix, et al.
Publicado: (2023)

Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival
por: Doherty, A P, et al.
Publicado: (2000)

Comparison of Pathological and Biochemical Outcomes after Radical Prostatectomy in Korean Patients with Serum PSA Ranges
por: Lee, Hye Won, et al.
Publicado: (2015)

Sacral insufficiency fracture after stereotactic body radiation therapy for sacral metastasis
por: Kawamoto, Terufumi, et al.
Publicado: (2018)

A phase II study of concurrent chemoradiotherapy with 5-fluorouracil and mitomycin-C for squamous cell carcinoma of the anal canal (the JROSG 10–2 trial)
por: Murofushi, Keiko Nemoto, et al.
Publicado: (2022)

Optimal timing of salvage radiotherapy for biochemical recurrence after radical prostatectomy: is ultra-early salvage radiotherapy beneficial?
por: Taguchi, Satoru, et al.
Publicado: (2016)

Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer
por: Onishi, Hiroshi, et al.
Publicado: (2018)

Initial and cumulative recurrence patterns of glioblastoma after temozolomide-based chemoradiotherapy and salvage treatment: a retrospective cohort study in a single institution
por: Ogura, Kengo, et al.
Publicado: (2013)

Predictive factors for disease progression after salvage radiation therapy in biochemical recurrent patients treated by radical prostatectomy
por: Aikawa, Koichi, et al.
Publicado: (2023)

Role of Dose Intensification for Salvage Radiation Therapy after Radical Prostatectomy
por: Beck, Marcus, et al.
Publicado: (2016)

The impact of intra-operative cell salvage during open radical prostatectomy
por: Kinnear, Ned, et al.
Publicado: (2018)

Postoperative or Salvage Proton Radiotherapy for Prostate Cancer After Radical Prostatectomy
por: Kharod, Shivam M., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fleio6nel085j1ljo2r2h7djcv